Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN146,8146,84-1,24
Msft0,10
Nokia9,96
IBM-0,95
Mercedes-Benz Group AG48,01548,0151,22
PFE0,15
13.06.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 12.06.2026
Pharma-Bio Serv (US Other OTC (Pink Sheets))
Závěr k 12.6.2026 Změna (%) Změna (USD) Objem obchodů (ks)
0,565 15,31 0,08 1 000
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.06.2026
Popis společnosti
Obecné informace
Název společnostiPharma-Bio Serv Inc
TickerPBSV
Kmenové akcie:Ordinary Shares
RICPBSV.PK
ISIN-
Prioritní akciePreference Shares
Poslední známé roční výsledky31.10.2025
Poslední známé čtvrtletní výsledky31.01.2026
Počet zaměstnanců k 31.10.2025 75
Akcie v oběhu k 13.03.2026 22 901 692
MěnaUSD
Kontaktní informace
UlicePharma-Bio Serv Building,#6 Road 696
MěstoDORADO
PSČ00646
ZeměPuerto Rico
Kontatní osobaScott Gordon
Funkce kontaktní osobyInvestor Relations
Telefon17 872 782 709
Kontatní telefon16 317 034 900

Business Summary: Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company services the Puerto Rico, United States, Europe and Latin America markets. The Company's core business is Food and Drug Administration (FDA) and international agencies regulatory compliance consulting related services. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetics and food industries, and allied products companies. The Company's services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company operates in three reportable business segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, and Europe technical compliance consulting. The Company markets its services with a presence in industry trade shows, professional conventions, industry publications and company-provided seminars to the industry.
Financial Summary: BRIEF: For the three months ended 31 January 2026, Pharma-Bio Serv Inc revenues decreased 7% to $2.3M. Net income increased from $9K to $33K. Revenues reflect Europe consulting segment decrease of 19% to $584K, United States consulting segment decrease of 15% to $547K, Europe segment decrease of 19% to $584K, United States segment decrease of 15% to $547K, Other Segments decrease from $1K to $0K.
Odvětvová klasifikace
TRBC2009Business Support - Services
TRBC2012Management Consulting Services
RBSS2004Commercial Services & Supplies
MGINDUSTRYBusiness Services
MGSECTORServices
NAICSOther Management Consulting Services
NAICSComputer Systems Design Services
NAICSAdministrative Management and General Management Consulting Services
NAICSAll Other Professional, Scientific, and Technical Services
NAICSMedical Laboratories
NAICS2007Other Management Consulting Services
NAICS2007Computer Systems Design Services
NAICS2007Admin & Gen Management Consulting Services
NAICS1997Other Management Consulting Services
NAICS1997Computer Systems Design Services
NAICS1997Administrative Management and General Management Consulting Services
SICManagement Consulting Services
SICBusiness Consulting, Nec
SICComputer Integrated System Design
SICManagement Consulting Services
SICBusiness Services, Nec
SICMedical Laboratories



  • Poslední aktualizace: 14.06.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, President, President of European OperationsVictor Sanchez5201.01.2015
Chief Financial Officer, Vice President - Finance and Administration, SecretaryPedro Lasanta6301.12.2014